$G

Genpact (NYSE: G) insider plans $368K stock sale

Genpact (G) insider Balkrishan Kalra plans to sell 10,000 shares, valued at $367,904, on 9/14/26 via Morgan Stanley. The sale is under Rule 144, which governs insider stock transactions. This may impact share supply and price.

Original reporting
Published Sep 14, 2026, 8:23 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 14, 2026, 8:51 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$G
Neutral
medium confidence
Mentioned
$G
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$GNeutralLow
01

Why it matters

The disclosed sale adds a modest amount of shares to the market, unlikely to move the price significantly.

02

Market read

Routine insider sale; low immediate trading relevance.

03

What to watch

Potential cumulative effect if other insiders also sell around the same time.

Relevance 4/10Novelty 4/10Timing: sale scheduled for today

Background

Genpact (NYSE:G) is a business process management firm. Rule 144 filings disclose planned sales of restricted shares.

Company-level read

Ticker impact

$GNeutralMedium confidence
Context

Insider Balkrishan Kalra filed a Rule 144 notice to sell 10,000 Genpact shares (~$368K) on Sep 14, 2026.

Expected impact

Minor downward pressure if the sale is executed quickly.

Evidence & confidence

The sale size is small relative to market cap; impact limited unless multiple insiders sell concurrently.

Market effects

No broader sector impact; insider sale is company‑specific.

Limited to US investors tracking Genpact.

Minimal global relevance.

Counterpoint

If insiders are selling, it could signal concerns, but the amount is too small to be material.

Key entities

  • Balkrishan Kalra

    Genpact employee filing the Rule 144 notice.

  • Morgan Stanley Smith Barney LLC

    Broker handling the planned sale.

Related articles

$GMed

Genpact Q2 Earnings Call Highlights

Genpact (NYSE:G) said it expects more than $1 billion in agentic total contract value in 2026, about 5x 2025. Management reported 3% net revenue growth and 300 bps gross-margin expansion from clients shifting to agentic delivery. Q2 gross margin rose to 36.5%, adjusted operating income was $234M, and adjusted EPS was $1.00. Genpact reaffirmed 2026 revenue growth of at least 7% and guided Q3 revenue to $1.369B-$1.382B.

$GMed

Genpact’s (NYSE:G) Q2 CY2026 Sales Beat Estimates

Genpact (NYSE:G) reported Q2 CY2026 revenue of $1.34 billion, up 7.1% year on year and 0.8% above estimates, according to the company. It guided next quarter revenue to about $1.38 billion. Adjusted EPS was $0.88, missing consensus, and the company said it expects Advanced Technology Solutions revenue to grow at least 25% for the full year.

$GHigh

Genpact LTD (G): Results of Operations and Financial Condition

Genpact LTD (G) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Genpact Reports Second Quarter 2026 Results Advanced Technology Solutions net revenue growth, up 24% year-over-year, drives Q2 performance NEW YORK, August 6, 2026 — Genpact Limited (NYSE: G), the Agentic Operations company, today announced financial results for the

$GMed

Deutsche Bank ranks IT Services stocks ahead of earnings By Investing.com

Deutsche Bank analyst Nate Svensson cut price targets across IT Services ahead of earnings, citing weaker enterprise demand into Q2 2026 from geopolitical uncertainty, higher rate expectations, and a softer macro backdrop. He flagged AI-driven productivity and disintermediation risks. Genpact PT $31, Accenture PT $136, Cognizant PT $55, EPAM PT $85, Globant PT $33.

$GMed

Why Genpact (G) Stock Is Up Today

Genpact (NYSE: G) shares rose about 2.7% after the company announced a partnership with Nestlé to set up a Global Capability Centre in Hyderabad, India. Genpact will support process intelligence, data, AI and automation to help Nestlé scale business services. The stock later traded around $29.72, up ~2.6% from the prior close.